A phase I/II multicenter, first-in-human study of DB-1311/ BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors

Y. Cheng; L. Wu; A. Parsonson; H. Amin; J. Shi; C. Lemech; Y. Sun; A. Schmidt; D. Lv; M. Li; T. Zheng; A. Chaudhry; C. Gandhi; Q. Wang; D. A. Montoya Motino; A. Abed; R. Tibes; X. Lu; V. Gu; A. E. Lisberg

doi:10.1016/j.annonc.2024.10.078

A phase I/II multicenter, first-in-human study of DB-1311/ BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors

Y. Cheng, L. Wu, A. Parsonson, H. Amin, J. Shi, C. Lemech, Y. Sun, A. Schmidt, D. Lv, M. Li, T. Zheng, A. Chaudhry, C. Gandhi, Q. Wang, D. A. Montoya Motino, A. Abed, R. Tibes, X. Lu, V. Gu, A. E. Lisberg

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	570
Pages (from-to)	S1426
Number of pages	1
Journal	Annals of Oncology
Volume	35
Issue number	Supplement 4
DOIs	https://doi.org/10.1016/j.annonc.2024.10.078
Publication status	Published - Dec 2024
Externally published	Yes
Event	European-Society-for-Medical-Oncology Asia Congress (ESMO) - Singapore, Singapore Duration: 6 Dec 2024 → 8 Dec 2024

Access to Document

10.1016/j.annonc.2024.10.078

Cite this

Cheng, Y., Wu, L., Parsonson, A., Amin, H., Shi, J., Lemech, C., Sun, Y., Schmidt, A., Lv, D., Li, M., Zheng, T., Chaudhry, A., Gandhi, C., Wang, Q., Motino, D. A. M., Abed, A., Tibes, R., Lu, X., Gu, V., & Lisberg, A. E. (2024). A phase I/II multicenter, first-in-human study of DB-1311/ BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors. Annals of Oncology, 35(Supplement 4), S1426. Article 570. https://doi.org/10.1016/j.annonc.2024.10.078

@article{870e57b13fe24c91bff904e0285e1b7e,

title = "A phase I/II multicenter, first-in-human study of DB-1311/ BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors",

author = "Y. Cheng and L. Wu and A. Parsonson and H. Amin and J. Shi and C. Lemech and Y. Sun and A. Schmidt and D. Lv and M. Li and T. Zheng and A. Chaudhry and C. Gandhi and Q. Wang and Motino, \{D. A. Montoya\} and A. Abed and R. Tibes and X. Lu and V. Gu and Lisberg, \{A. E.\}",

year = "2024",

month = dec,

doi = "10.1016/j.annonc.2024.10.078",

language = "English",

volume = "35",

pages = "S1426",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Supplement 4",

note = "European-Society-for-Medical-Oncology Asia Congress (ESMO) ; Conference date: 06-12-2024 Through 08-12-2024",

}

Cheng, Y, Wu, L, Parsonson, A, Amin, H, Shi, J, Lemech, C, Sun, Y, Schmidt, A, Lv, D, Li, M, Zheng, T, Chaudhry, A, Gandhi, C, Wang, Q, Motino, DAM, Abed, A, Tibes, R, Lu, X, Gu, V & Lisberg, AE 2024, 'A phase I/II multicenter, first-in-human study of DB-1311/ BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors', Annals of Oncology, vol. 35, no. Supplement 4, 570, pp. S1426. https://doi.org/10.1016/j.annonc.2024.10.078

TY - JOUR

T1 - A phase I/II multicenter, first-in-human study of DB-1311/ BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors

AU - Cheng, Y.

AU - Wu, L.

AU - Parsonson, A.

AU - Amin, H.

AU - Shi, J.

AU - Lemech, C.

AU - Sun, Y.

AU - Schmidt, A.

AU - Lv, D.

AU - Li, M.

AU - Zheng, T.

AU - Chaudhry, A.

AU - Gandhi, C.

AU - Wang, Q.

AU - Motino, D. A. Montoya

AU - Abed, A.

AU - Tibes, R.

AU - Lu, X.

AU - Gu, V.

AU - Lisberg, A. E.

PY - 2024/12

Y1 - 2024/12

U2 - 10.1016/j.annonc.2024.10.078

DO - 10.1016/j.annonc.2024.10.078

M3 - Meeting abstract

SN - 0923-7534

VL - 35

SP - S1426

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 4

M1 - 570

T2 - European-Society-for-Medical-Oncology Asia Congress (ESMO)

Y2 - 6 December 2024 through 8 December 2024

ER -